Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tavridou

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Omics : a Journal of Integrative Biology|November 28, 2017
Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter MethylationEfstathia Giannakopoulou, Fotios Konstantinou, Georgia Ragia, et al.
Journal of Diabetes Research|June 12, 2015
Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic NephropathyAnna Tavridou, Anastasia Georgoulidou, Athanasios Roumeliotis, et al.
Journal of Cardiovascular Pharmacology|June 4, 2008
Antiatherosclerotic properties of EP2302, a novel squalene synthase inhibitor, in the cholesterol-fed rabbitAnna Tavridou, Loukas Kaklamanis, Apostolos Papalois, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndromeAndromachi Vryonidou, Athanasios Papatheodorou, Anna Tavridou, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2007
EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbitAnna Tavridou, Loukas Kaklamanis, Apostolos Papalois, et al.
The Open Cardiovascular Medicine Journal|March 22, 2014
Impact of CYP3A5 Gene Polymorphism on Efficacy of SimvastatinGenovefa Kolovou, Georgia Ragia, Vana Kolovou, et al.
Pharmacogenetics and Genomics|January 15, 2008
The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female CaucasiansMaria Iordanidou, Anna Tavridou, Michalis V Vasiliadis, et al.
Omics : a Journal of Integrative Biology|October 30, 2014
Vitamin D receptor ApaI a allele is associated with better childhood asthma control and improvement in ability for daily activitiesMaria Iordanidou, Emmanouil Paraskakis, Efstathia Giannakopoulou, et al.
Molecular Diagnosis & Therapy|January 17, 2014
Lack of association of the p450 oxidoreductase *28 single nucleotide polymorphism with the lipid-lowering effect of statins in hypercholesterolemic patientsGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
Pharmacogenomics|December 15, 2016
A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trialGeorgia Ragia, Vana Kolovou, Genovefa Kolovou, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Omics : a Journal of Integrative Biology|November 28, 2017
Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter MethylationEfstathia Giannakopoulou, Fotios Konstantinou, Georgia Ragia, et al.
Journal of Diabetes Research|June 12, 2015
Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic NephropathyAnna Tavridou, Anastasia Georgoulidou, Athanasios Roumeliotis, et al.
Journal of Cardiovascular Pharmacology|June 4, 2008
Antiatherosclerotic properties of EP2302, a novel squalene synthase inhibitor, in the cholesterol-fed rabbitAnna Tavridou, Loukas Kaklamanis, Apostolos Papalois, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndromeAndromachi Vryonidou, Athanasios Papatheodorou, Anna Tavridou, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2007
EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbitAnna Tavridou, Loukas Kaklamanis, Apostolos Papalois, et al.
The Open Cardiovascular Medicine Journal|March 22, 2014
Impact of CYP3A5 Gene Polymorphism on Efficacy of SimvastatinGenovefa Kolovou, Georgia Ragia, Vana Kolovou, et al.
Pharmacogenetics and Genomics|January 15, 2008
The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female CaucasiansMaria Iordanidou, Anna Tavridou, Michalis V Vasiliadis, et al.
Omics : a Journal of Integrative Biology|October 30, 2014
Vitamin D receptor ApaI a allele is associated with better childhood asthma control and improvement in ability for daily activitiesMaria Iordanidou, Emmanouil Paraskakis, Efstathia Giannakopoulou, et al.
Molecular Diagnosis & Therapy|January 17, 2014
Lack of association of the p450 oxidoreductase *28 single nucleotide polymorphism with the lipid-lowering effect of statins in hypercholesterolemic patientsGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
Pharmacogenomics|December 15, 2016
A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trialGeorgia Ragia, Vana Kolovou, Genovefa Kolovou, et al.
Pageof 5